EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

45 hedge funds and large institutions have $174M invested in Eidos Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$44M
2
+$40.4M
3
+$14M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.46M
5
DM
Deerfield Management
New York
+$6.59M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$589K
27
$528K
28
$509K
29
$281K
30
$229K
31
$220K
32
$203K
33
$203K
34
$183K
35
$163K
36
$111K
37
$110K
38
$91K
39
$71K
40
$52K
41
$34K
42
$32K
43
$30K
44
$20K
45
$8K
46
$6K
1
2